HIV-hepatitis C virus co-infection in the era of direct-acting antivirals.
about
Hepatitis C virus: Virology, diagnosis and treatmentA Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected PatientsManagement of lipid disorders in patients living with HIV.Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir: A Review in Chronic HCV Genotype 1 Infection.Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study.
P2860
HIV-hepatitis C virus co-infection in the era of direct-acting antivirals.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
HIV-hepatitis C virus co-infection in the era of direct-acting antivirals.
@en
type
label
HIV-hepatitis C virus co-infection in the era of direct-acting antivirals.
@en
prefLabel
HIV-hepatitis C virus co-infection in the era of direct-acting antivirals.
@en
P2093
P2860
P1476
HIV-hepatitis C virus co-infection in the era of direct-acting antivirals.
@en
P2093
Douglas T Dieterich
Kian Bichoupan
Valérie Martel-Laferrière
P2860
P2888
P304
P356
10.1007/S11904-014-0217-9
P577
2014-09-01T00:00:00Z